NIH’s ODS Strategic Plan Adds Steering Group To Monitor Progress
This article was originally published in The Tan Sheet
Executive Summary
NIH's Office of Dietary Supplements is instituting a steering group and an annual "external consultative group meeting" in order to review and evaluate its ongoing programs
You may also be interested in...
ODS Role As Government Key Advisor Must Be Strengthened – Israelsen
The Office of Dietary Supplements should make HHS and FDA "recognize the ODS as [their] key advisor" on supplement issues, Utah Natural Products Alliance Executive Director Loren Israelsen said May 8
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands